[HTML] plos.org

[HTML][HTML] SimB16: modeling induced immune system response against B16-melanoma

F Pappalardo, IM Forero, M Pennisi, A Palazon… - PloS one, 2011 - journals.plos.org
Immunological therapy of progressive tumors requires not only activation and expansion of
tumor specific cytotoxic T lymphocytes (CTLs), but also an efficient effector phase including …
被引用次数：70 相关文章

SimB16: Modeling Induced Immune System Response against B16-Melanoma.

F Pappalardo, IM Forero, M Pennisi, A Palazon… - PLoS …, 2011 - search.ebscohost.com
Immunological therapy of progressive tumors requires not only activation and expansion of
tumor specific cytotoxic T lymphocytes (CTLs), but also an efficient effector phase including …
[PDF] psu.edu

[PDF][PDF] SimB16: Modeling Induced Immune System Response against B16-Melanoma

F Pappalardo, IM Forero, M Pennisi, A Palazon… - 2011 - Citeseer
Immunological therapy of progressive tumors requires not only activation and expansion of
tumor specific cytotoxic T lymphocytes (CTLs), but also an efficient effector phase including …

[引用][C] SimB16: Modeling Induced Immune System Response against B16-Melanoma

F Pappalardo, IM Forero, M Pennisi, A Palazon… - PLoS …, 2011 - ui.adsabs.harvard.edu
SimB16: Modeling Induced Immune System Response against B16-Melanoma - NASA/ADS
Now on home page ads icon ads Enable full ADS view NASA/ADS SimB16: Modeling Induced …

[引用][C] SimB16: Modeling Induced Immune System Response against B16-Melanoma

F Pappalardo, IM Forero, M Pennisi, A Palazon… - PLoS ONE, 2011 - cir.nii.ac.jp
SimB16: Modeling Induced Immune System Response against B16-Melanoma | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
[PDF] academia.edu

[PDF][PDF] SimB16: Modeling Induced Immune System Response against B16-Melanoma

F Pappalardo, IM Forero, M Pennisi, A Palazon… - 2011 - academia.edu
Immunological therapy of progressive tumors requires not only activation and expansion of
tumor specific cytotoxic T lymphocytes (CTLs), but also an efficient effector phase including …
[PDF] researchgate.net

[PDF][PDF] SimB16: Modeling Induced Immune System Response against B16-Melanoma

F Pappalardo, IM Forero, M Pennisi, A Palazon… - 2011 - researchgate.net
Immunological therapy of progressive tumors requires not only activation and expansion of
tumor specific cytotoxic T lymphocytes (CTLs), but also an efficient effector phase including …

SimB16: modeling induced immune system response against B16-melanoma

F Pappalardo, I Martinez-Forero, M Pennisi, A Palazon… - 2011 - dadun.unav.edu
Immunological therapy of progressive tumors requires not only activation and expansion of
tumor specific cytotoxic T lymphocytes (CTLs), but also an efficient effector phase including …
[PDF] unict.it

[PDF][PDF] SimB16: Modeling Induced Immune System Response against B16-Melanoma

F Pappalardo, IM Forero, M Pennisi, A Palazon… - 2011 - iris.unict.it
Immunological therapy of progressive tumors requires not only activation and expansion of
tumor specific cytotoxic T lymphocytes (CTLs), but also an efficient effector phase including …
[PDF] semanticscholar.org

[PDF][PDF] SimB16: Modeling Induced Immune System Response against B16-Melanoma

F Pappalardo, IM Forero, M Pennisi, A Palazon… - 2011 - pdfs.semanticscholar.org
Immunological therapy of progressive tumors requires not only activation and expansion of
tumor specific cytotoxic T lymphocytes (CTLs), but also an efficient effector phase including …